Which ETFs own 4114.TWO?
Synmosa Biopharma Corporation · Healthcare · Drug Manufacturers - Specialty & Generic · TW — 8 ETFs hold it, worth $9.0M across 9.55M shares.
Holdings as of Oct 13, 2026 · portfolio reporting dates from the data provider; not live positions.
| # | ETF | Weight | Shares | Value | ETF AUM | Category | Today | |
|---|---|---|---|---|---|---|---|---|
| 1 | AVEE Avantis Emerging Markets Small Cap… | 0.03% | 48.06K | $45.3K | $139.8M | Emerging Markets | -0.40% | |
| 2 | DEXC Dimensional - Emerging Markets ex China… | 0.01% | 44.12K | $41.7K | $299.1M | Emerging Markets | -0.85% | |
| 3 | DFEV Dimensional - Emerging Markets Value ETF | 0.01% | 273.65K | $258.9K | $2.19B | Emerging Markets | -0.31% | |
| 4 | VSS Vanguard FTSE All-World ex-US Small-Cap… | 0.01% | 1.80M | $1.7M | $14.50B | Developed Markets | +0.07% | |
| 5 | DFSE Dimensional Emerging Markets… | 0.01% | 56.76K | $53.7K | $642.7M | Emerging Markets | -0.33% | |
| 6 | DFEM Dimensional - Emerging Markets Core… | 0.01% | 618.49K | $585.3K | $9.67B | Emerging Markets | -0.53% | |
| 7 | DFAE Dimensional - Emerging Core Equity… | 0.00% | 395.19K | $374.0K | $10.11B | Emerging Markets | -0.46% | |
| 8 | VWO Vanguard FTSE Emerging Markets ETF | 0.00% | 6.31M | $5.9M | $168.50B | Emerging Markets | -0.08% |
Coverage reflects the ETF portfolios loaded in our database; very small funds may not be swept yet. Market data delayed approximately 15–20 minutes unless otherwise indicated.